Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011

A Potron1, L Poirel, E Rondinaud

  • 1INSERM U914, Emerging Resistance to Antibiotics, Faculté de Médecine et Université Paris-Sud, K. Bicêtre, France.

Insights

OXA-48 beta-lactamase-producing bacteria are a growing threat, particularly in the Mediterranean. This study tracked their spread in Europe and North Africa, finding widespread resistance to ertapenem but susceptibility to colistin and tigecycline.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • OXA-48 beta-lactamase-producing Enterobacteriaceae pose a significant and increasing threat, especially in the Mediterranean region.
  • Understanding the molecular epidemiology of these resistant strains is crucial for public health surveillance and control.

Purpose of the Study:

  • To investigate the molecular epidemiology of OXA-48 beta-lactamase-positive Enterobacteriaceae isolates collected across Europe and North Africa.
  • To characterize the antimicrobial resistance profiles, genetic relatedness, and plasmid-mediated dissemination of bla(OXA-48).

Main Methods:

  • Analysis of 107 Enterobacteriaceae isolates (Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae) collected between 2001 and 2011.
  • Antimicrobial susceptibility testing using EUCAST breakpoints.
  • Multilocus sequence typing (MLST) and plasmid analysis to determine genetic relationships and bla(OXA-48) gene location.

Main Results:

  • Most isolates showed resistance to ertapenem (91.6%) but remained susceptible to imipenem (66%).
  • Co-production of extended-spectrum beta-lactamases, notably CTX-M-15 (77.5%), was common.
  • Colistin, tigecycline, amikacin, and fosfomycin demonstrated sustained activity.
  • MLST identified common sequence types (ST101 for K. pneumoniae, ST38 for E. coli).
  • The bla(OXA-48) gene was predominantly located on a 62 kb IncL/M plasmid (92.5%).

Conclusions:

  • OXA-48-producing Enterobacteriaceae have spread widely across Europe and North Africa, with evidence of importation and endemicity in some regions.
  • The IncL/M plasmid is a key vehicle for bla(OXA-48) dissemination.
  • Maintaining surveillance and understanding resistance mechanisms are vital to combat the spread of these multidrug-resistant organisms.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...